Company / Gross Profit
Eton Pharmaceuticals, Inc. Gross Profit History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$21.1M
FY2025
5-year range
-$397.0K / $21.1M
FY2021-FY2025
Trend
+47.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has fluctuated over the past 7 years, ranging from -$397,000 in FY2022 to $21M in FY2025.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +110.8%.
Improved from $19M to $21M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +110.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +110.8%, indicating consistent growth.
- In FY2025, gross profit increased 47.1% year-over-year.
- Lowest gross profit in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.1M | +47.1% |
| FY2024 | $14.3M | -24.7% |
| FY2023 | $19.0M | +4887.2% |
| FY2022 | -$397.0K | -178.5% |
| FY2021 | $506.0K | +0.0% |
| FY2020 | $506.0K | +0.0% |
| FY2019 | $506.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026